AU2023259147A1 - Systems, devices, and methods for meal-related analyte response monitoring - Google Patents
Systems, devices, and methods for meal-related analyte response monitoring Download PDFInfo
- Publication number
- AU2023259147A1 AU2023259147A1 AU2023259147A AU2023259147A AU2023259147A1 AU 2023259147 A1 AU2023259147 A1 AU 2023259147A1 AU 2023259147 A AU2023259147 A AU 2023259147A AU 2023259147 A AU2023259147 A AU 2023259147A AU 2023259147 A1 AU2023259147 A1 AU 2023259147A1
- Authority
- AU
- Australia
- Prior art keywords
- meal
- challenge
- user
- analyte
- analyte level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012054 meals Nutrition 0.000 title claims abstract description 1056
- 239000012491 analyte Substances 0.000 title claims abstract description 703
- 230000004044 response Effects 0.000 title claims abstract description 303
- 238000000034 method Methods 0.000 title claims abstract description 93
- 238000012544 monitoring process Methods 0.000 title claims description 267
- 230000002641 glycemic effect Effects 0.000 claims abstract description 79
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 77
- 239000008103 glucose Substances 0.000 claims abstract description 77
- 235000013305 food Nutrition 0.000 claims description 144
- 230000015654 memory Effects 0.000 claims description 86
- 238000004891 communication Methods 0.000 claims description 82
- 230000006854 communication Effects 0.000 claims description 82
- 230000000694 effects Effects 0.000 claims description 29
- 230000006870 function Effects 0.000 claims description 23
- 230000006399 behavior Effects 0.000 claims description 11
- 230000007704 transition Effects 0.000 claims description 11
- 210000001124 body fluid Anatomy 0.000 claims description 10
- 238000004458 analytical method Methods 0.000 claims description 6
- 238000005259 measurement Methods 0.000 abstract description 13
- 238000012545 processing Methods 0.000 description 20
- 238000001727 in vivo Methods 0.000 description 19
- 238000010586 diagram Methods 0.000 description 16
- 238000012377 drug delivery Methods 0.000 description 13
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 9
- 230000005540 biological transmission Effects 0.000 description 8
- 230000037213 diet Effects 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 235000013550 pizza Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 235000021152 breakfast Nutrition 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000021158 dinner Nutrition 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 230000001932 seasonal effect Effects 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 3
- 208000001145 Metabolic Syndrome Diseases 0.000 description 3
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000021156 lunch Nutrition 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000003811 finger Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000010295 mobile communication Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 230000006461 physiological response Effects 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 239000004984 smart glass Substances 0.000 description 2
- 235000011888 snacks Nutrition 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 238000012384 transportation and delivery Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 241000972773 Aulopiformes Species 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 101150049278 US20 gene Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000007175 bidirectional communication Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000013605 boiled eggs Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013523 data management Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 235000020803 food preference Nutrition 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 235000021180 meal component Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/742—Details of notification to user or communication with user or patient; User input means using visual displays
- A61B5/7435—Displaying user selection data, e.g. icons in a graphical user interface
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- Signal Processing (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Optics & Photonics (AREA)
- Mathematical Physics (AREA)
- Human Computer Interaction (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Developmental Disabilities (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263335030P | 2022-04-26 | 2022-04-26 | |
| US63/335,030 | 2022-04-26 | ||
| US202363452263P | 2023-03-15 | 2023-03-15 | |
| US63/452,263 | 2023-03-15 | ||
| PCT/US2023/019874 WO2023211986A1 (en) | 2022-04-26 | 2023-04-25 | Systems, devices, and methods for meal-related analyte response monitoring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023259147A1 true AU2023259147A1 (en) | 2024-10-31 |
Family
ID=86497420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023259147A Pending AU2023259147A1 (en) | 2022-04-26 | 2023-04-25 | Systems, devices, and methods for meal-related analyte response monitoring |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230404441A1 (enExample) |
| EP (1) | EP4515566A1 (enExample) |
| JP (1) | JP2025514181A (enExample) |
| CN (1) | CN119256370A (enExample) |
| AU (1) | AU2023259147A1 (enExample) |
| CA (1) | CA3249156A1 (enExample) |
| WO (1) | WO2023211986A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12582871B2 (en) * | 2024-01-11 | 2026-03-24 | Motorola Mobility Llc | Activity tracking for multiple users on a device |
| US20250316358A1 (en) * | 2024-04-04 | 2025-10-09 | Diabasal, LLC | Diabetic pump, application, and programming |
| WO2025212628A1 (en) | 2024-04-04 | 2025-10-09 | Tc1 Llc | Method and device for cardiac pressure sensing using an active implantable device and near field communication |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
| JP5795584B2 (ja) | 2009-08-31 | 2015-10-14 | アボット ダイアベティス ケア インコーポレイテッドＡｂｂｏｔｔ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｉｎｃ． | 医療用装置 |
| WO2012108938A1 (en) | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Software applications residing on handheld analyte determining devices |
| ES2984055T3 (es) | 2011-09-28 | 2024-10-28 | Abbott Diabetes Care Inc | Procedimientos para la gestión de monitorización de analitos y gestión de los datos de medición de analitos, y artículos de fabricación relacionados con los mismos |
| US20140012511A1 (en) * | 2012-07-09 | 2014-01-09 | Dexcom, Inc. | Systems and methods for leveraging smartphone features in continuous glucose monitoring |
| CA2895538A1 (en) | 2013-03-15 | 2014-09-18 | Abbott Diabetes Care Inc. | System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk |
| US20170185748A1 (en) | 2014-03-30 | 2017-06-29 | Abbott Diabetes Care Inc. | Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems |
| US10667633B2 (en) | 2016-11-04 | 2020-06-02 | Clearman Labs Llc | Integrated ground-affixing systems, devices, and methods for ground covers |
| US20210030323A1 (en) | 2019-08-02 | 2021-02-04 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
| US12131661B2 (en) * | 2019-10-03 | 2024-10-29 | Willow Laboratories, Inc. | Personalized health coaching system |
| EP4176447A1 (en) | 2020-07-01 | 2023-05-10 | Abbott Diabetes Care Inc. | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation |
-
2023
- 2023-04-25 CN CN202380041843.3A patent/CN119256370A/zh active Pending
- 2023-04-25 US US18/139,314 patent/US20230404441A1/en active Pending
- 2023-04-25 CA CA3249156A patent/CA3249156A1/en active Pending
- 2023-04-25 JP JP2024563260A patent/JP2025514181A/ja active Pending
- 2023-04-25 EP EP23725889.2A patent/EP4515566A1/en active Pending
- 2023-04-25 AU AU2023259147A patent/AU2023259147A1/en active Pending
- 2023-04-25 WO PCT/US2023/019874 patent/WO2023211986A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023211986A1 (en) | 2023-11-02 |
| CA3249156A1 (en) | 2023-11-02 |
| EP4515566A1 (en) | 2025-03-05 |
| US20230404441A1 (en) | 2023-12-21 |
| JP2025514181A (ja) | 2025-05-02 |
| CN119256370A (zh) | 2025-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12502102B2 (en) | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation | |
| US20250191740A1 (en) | Systems, devices, and methods for episode detection and evaluation with intervention guides, action plans and/or scheduling interfaces | |
| US12424326B2 (en) | Systems, devices, and methods for episode detection and evaluation | |
| US20250095869A1 (en) | Software applications residing on handheld analyte determining devices | |
| US20240293051A1 (en) | Intermittent monitoring | |
| US20210030323A1 (en) | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation | |
| US20220273204A1 (en) | Intermittent Monitoring | |
| US20180197628A1 (en) | Systems, devices, and methods for experiential medication dosage calculations | |
| US20230404441A1 (en) | Systems, devices, and methods for meal-related analyte response monitoring | |
| US20230207090A1 (en) | Systems, devices, and methods for dosing pattern management | |
| JP2023528157A5 (enExample) | ||
| CA3256364A1 (en) | COST-EFFECTIVE THERAPY RECOMMENDATIONS | |
| US20240215871A1 (en) | Systems, devices, and methods for time-in-range and meal-related analyte monitoring | |
| US20250311945A1 (en) | Systems, devices, and methods for time-in-range and meal-related analyte monitoring |